Jun 01, 2023 / 05:50PM GMT
Jonathan David Block - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst
Thanks, guys. Jon Block with Stifel. Good afternoon. I'm sticking with the pause theme. And next, we have Elanco Animal Health, one of the largest players in the animal health industry. And joining us is Todd Young, the company's CFO. I'm going to lead the Q&A. Guys, if you have questions, just throw up your hand. Obviously, you'll take precedent, and I'm going to turn on my mic as well, I believe. I'm on. Can you hear me? Better? Okay. I'm not going to repeat all that, but let's get going, and I'll fire away with some questions. Todd, thanks for joining.
Questions and Answers:
Jonathan David Block - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research AnalystI'm going to get right into things with Seresto. And on the first quarter earnings call, Jeff talked to some formal results to be communicated by the EPA in the coming weeks. I think we've got a couple of these. Like here it